DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Pilot Study to Improve Medication Management in Older Adults

Not Applicable

Completed

Conditions: Medication Adherence

Interventions: Other: Tailored Medication Management Intervention

First Posted Date: 2021-01-14

Last Posted Date: 2023-07-19

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 4

Registration Number: NCT04709640

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell

Not Applicable

Completed

Conditions: COVID-19 Pandemic
Covid19
Hypogeusia
Hyposmia
Ageusia
SARS-CoV-2 Infection
Anosmia

Interventions: Behavioral: Smell Training

First Posted Date: 2021-01-14

Last Posted Date: 2022-06-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 240

Registration Number: NCT04710394

Locations: 🇺🇸
Washington University School of Medicine in Saint Louis, Saint Louis, Missouri, United States

Evaluating the Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rates: The BASICS Trial

Not Applicable

Withdrawn

Conditions: Colposcopy

Interventions: Other: Usual Care Reminder Call
Other: 2-1-1 United Way Healthy Missouri Hotline
Other: National Comprehensive Cancer Network (NCCN) Distress Thermometer
Other: Basic needs survey
Other: 2-1-1 survey

First Posted Date: 2021-01-11

Last Posted Date: 2022-06-29

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT04704011

Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies

Not Applicable

Active, not recruiting

Conditions: Alzheimer Disease
Dementia of Alzheimer Type

Interventions: Other: Arm A , Arm B, Arm C, & Arm D

First Posted Date: 2021-01-07

Last Posted Date: 2025-02-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 450

Registration Number: NCT04699786

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study

Phase 2

Active, not recruiting

Conditions: Alzheimer Disease, Early Onset
Mild Cognitive Impairment

Interventions: Other: Placebo Capsules
Drug: Dasatinib + Quercetin

First Posted Date: 2020-12-28

Last Posted Date: 2025-03-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 48

Registration Number: NCT04685590

Locations: 🇺🇸
Wake Forest Health Sciences, Winston-Salem, North Carolina, United States
🇪🇸
Fundación ACE Clinical Site, Barcelona, Spain
🇪🇸
Hospital Clínic de Barcelona Site, Barcelona, Spain

and more 2 locations

Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT

Not Applicable

Terminated

Conditions: Squamous Cell Carcinoma

Interventions: Device: Diffusion-weighted imaging magnetic resonance imaging
Device: FDG PET/CT

First Posted Date: 2020-12-28

Last Posted Date: 2023-10-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 8

Registration Number: NCT04685798

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Cardiac Markers in Depressed Patients With Coronary Heart Disease - R01HL147862

Recruiting

Conditions: Coronary Heart Disease
Depression

Interventions: Other: Other

First Posted Date: 2020-12-24

Last Posted Date: 2024-03-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 175

Registration Number: NCT04682769

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Placebo
Drug: Uproleselan
Drug: Melphalan

First Posted Date: 2020-12-23

Last Posted Date: 2023-12-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 51

Registration Number: NCT04682405

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) I

Phase 1

Active, not recruiting

Conditions: Treatment-resistant Depression

Interventions: Drug: Propofol
Diagnostic Test: Electroencephalography (EEG)
Diagnostic Test: Slow-Wave Activity

First Posted Date: 2020-12-23

Last Posted Date: 2024-12-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT04680910

Locations: 🇺🇸
Washington University School of Medicine/Barnes-Jewish Hospital, Saint Louis, Missouri, United States

Treatment of Angiotensin Converting Enzyme Inhibitor-induced Angioedema

Phase 2

Terminated

Conditions: Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor

Interventions: Other: Normal Saline
Biological: High ACE Activity Fresh Frozen Plasma

First Posted Date: 2020-12-22

Last Posted Date: 2024-03-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2

Registration Number: NCT04679311

Locations: 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy